503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
View analysts' price targets and recommendations, and compare them with competitors.
$601.38
Analysts expect the stock price to increase by 17.94%.
Buy
Positive consensus among analysts.
Analyze DCF forecasts for the company and compare them with competitors.
421.46B
Revenue has increased from the previous period.
14.51%
Revenue growth rate is unchanged from the previous period.
212.51B
EBITDA has increased from the previous period.
50.42%
EBITDA margin is unchanged from the previous period.
180.47B
EBIT has increased from the previous period.
42.82%
EBIT margin is unchanged from the previous period.
32.04B
Depreciation has increased from the previous period.
260.53B
Total cash has increased from the previous period.
61.82%
Cash percentage is unchanged from the previous period.
95.70B
Receivables have increased from the previous period.
22.71%
Receivables percentage is unchanged from the previous period.
5.45B
Inventories have increased from the previous period.
1.29%
Inventory percentage is unchanged from the previous period.
37.83B
Accounts payable has increased from the previous period.
8.98%
Payables percentage is unchanged from the previous period.
-56.07B
Capital expenditure has increased from the previous period.
-13.30%
CapEx percentage is unchanged from the previous period.
8.39%
WACC is unchanged from the previous period.
8.53%
Cost of equity is unchanged from the previous period.
4.26%
Cost of debt is unchanged from the previous period.
0.90
Beta is unchanged from the previous period.
7.47B
Diluted shares outstanding is unchanged from the previous period.
97.85B
Total debt is unchanged from the previous period.
3.37T
Total equity is unchanged from the previous period.
3.47T
Total capital is unchanged from the previous period.
2.82%
Debt weighting is unchanged from the previous period.
97.18%
Equity weighting is unchanged from the previous period.
151.36B
EBIAT has increased from the previous period.
119.30B
UFCF has increased from the previous period.
4.00%
Long-term growth rate is unchanged from the previous period.
3.24T
Terminal value is unchanged from the previous period.
2.57T
Enterprise value is unchanged from the previous period.
79.54B
Net debt is unchanged from the previous period.
2.50T
Equity value is unchanged from the previous period.
334.07
Equity value per share is unchanged from the previous period.
Analyze analyst forecasts for the company and compare them with competitors.
59.99B
The estimated revenue has increased from the previous period.
26.58B
The estimated EBITDA has increased from the previous period.
1.87
The estimated EPS has increased from the previous period.
18.22B
The estimated net income has increased from the previous period.
23.38B
The estimated EBIT has increased from the previous period.
15.49B
The estimated SG&A expenses have increased from the previous period.
